Abstract

Introduction

One of the most frequent side effects seen when prescribing sertraline and clozapine together is the appearance of a seizure crisis. This event is usually related to an increase of plasmatic concentration due to interactions of these drugs with blood components.

Objectives

To investigate the effects of clozapine when combined with other drugs, especially its effects increasing plasmatic concentration.

Methods

A patient was treated sith 300 mg/day of clozapine followed by a treatment with sertraline 50 mg/day, which increases plasmatic concentration. The combination of these treatments produced seizures. Other works published about interactions are reviewed.

Results

It is important to monitor clozapine dosages to avoid increasing plasmatic concentration, especially if other drugs that have this effect are also administered.

Conclusions

It is important to monitor clozapine dosages to avoid increasing plasmatic concentration, especially if other drugs that have this effect are also administered.

Disclosure

No significant relationships.

Details

Title
Monitoring sertraline and clozapine levels
Author
A Rodriguez Campos 1 ; L Rodriguez Andrés 1 ; G Medina Ojeda 1 ; I Santos Carrasco 2 ; J Gonçalves Cerejeira 3 ; Gonzaga, A 4 

 Hospital Clinico Universitario de Valladolid, Departamento De Psiquiatría, Valladolid, Spain 
 Clinical Hospital of Valladolid, Psychiatry, Valladolid, Spain 
 Hospital Clínico Universitario de Valladolid, Psychiatry, Valladolid, Spain 
 HOSPITAL CLINICO UNIVERSITARIO DE VALLADOLID, Psiquiatria, VALLADOLID, Spain 
Pages
S718-S718
Publication year
2022
Publication date
Jun 2022
Publisher
Cambridge University Press
ISSN
09249338
e-ISSN
17783585
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2708671581
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.